Researchers from the University of Central Florida recently received a $400,000 grant from the Juvenile Diabetes Research Foundation, which they will use to create a tube that resists infection and encapsulation and is inserted under the skin for the delivery of insulin via a pump.
Featured
Industry News NOVARTIS CORPORATION: Novartis announces FDA approval of Gilenya® as the first disease-modifying therapy for pediatric relapsing multiple sclerosis
Latest News
Innovation ACTINIUM PHARMACEUTICALS: Appoints Qing Liang, PhD, DABR as Vice President, Head of Radiation Sciences to Further Innovation for its AWE Technology Platform and Growing Pipeline of Antibody Radiation Conjugate Therapies
Federal Issues
- U.S. DEPARTMENT OF HOMELAND SECURITY: DHS Statement on Protecting the Nation from Foreign Terrorist Entry to the United States
- PHARMACEUTICAL CARE MANAGEMENT CARE ASSOCIATION: Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
- PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
- U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: HHS Secretary Azar Praises FDA Approval of First Non-Opioid Treatment for Opioid Withdrawal
Industry News
SAFE RX: Announces Availability in AmerisourceBergen
- SOPHiA GENETICS: Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine
- MYLAN N.V.: Sanofi's Formulation Patents on Multibillion-Dollar Lantus® are Invalidated by U.S. Patent and Trademark Office via IPR, Announces Mylan
- FIMBRION THERAPEUTICS, INC.: Fimbrion and GSK Identify Novel, Antibiotic-Sparing Development Candidate for Urinary Tract Infections
- U.S. FOOD AND DRUG ADMINISTRATION: Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice
Innovation
- VAST THERAPEUTICS: Announces Results Showing Ability to Eradicate Anthrax
- SANA BIOTECHNOLOGY: Launches Focusing on Engineering Cells to Create a New Class of Medicines
- CERTARA: US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants
- AMGEN: Makes Repatha® (Evolocumab) Available In The US At A 60 Percent Reduced List Price
Regulatory
- TEVA PHARMACEUTICAL INDUSTRIES, LTD: Announces US Launch of a Generic Version of Elidel®(Pimecrolimus) Cream, 1%
- ACORDA THERAPEUTICS, INC.: Announces FDA Approval of INBRIJA™ (levodopa inhalation powder)
- VAST THERAPEUTICS: Announces Funding from Cystic Fibrosis Foundation for Further Development of BIOC51
- DAIICHI SANKYO, INC.: FDA Grants Priority Review for Daiichi Sankyo's New Drug Application for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Alerts Sign-up